Barbosa P - Search Results

1

Activation of virus replication after vaccination of HIV-1-infected individuals.

Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB. Staprans SI, et al. Among authors: barbosa p. J Exp Med. 1995 Dec 1;182(6):1727-37. doi: 10.1084/jem.182.6.1727. J Exp Med. 1995. PMID: 7500017 Free PMC article. Clinical Trial.

2

The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable.

Sinclair E, Barbosa P, Feinberg MB. Sinclair E, et al. Among authors: barbosa p. J Virol. 1997 May;71(5):3641-51. doi: 10.1128/JVI.71.5.3641-3651.1997. J Virol. 1997. PMID: 9094638 Free PMC article.

3

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: barbosa p. J Immunol. 1996 Apr 1;156(7):2616-23. J Immunol. 1996. PMID: 8786327

4

Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.

Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD. Harrer T, et al. Among authors: barbosa p. J Immunol. 1998 Nov 1;161(9):4875-81. J Immunol. 1998. PMID: 9794421

5

Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.

Harrer E, Harrer T, Barbosa P, Feinberg M, Johnson RP, Buchbinder S, Walker BD. Harrer E, et al. Among authors: barbosa p. J Infect Dis. 1996 Feb;173(2):476-9. doi: 10.1093/infdis/173.2.476. J Infect Dis. 1996. PMID: 8568316

6

Characterization of plantar verrucae among individuals with human immunodeficiency virus.

Meberg R, Kenyon E, Bierman R, Loveland L, Barbosa P. Meberg R, et al. Among authors: barbosa p. J Am Podiatr Med Assoc. 1998 Sep;88(9):442-5. doi: 10.7547/87507315-88-9-442. J Am Podiatr Med Assoc. 1998. PMID: 9770936

7

Molecular biology of HIV.

Barbosa P, Kneass Z. Barbosa P, et al. Clin Podiatr Med Surg. 1998 Apr;15(2):189-202. Clin Podiatr Med Surg. 1998. PMID: 9576049 Review.

8

Human papilloma virus type 69 identified in a clinically aggressive plantar verruca from an HIV-positive patient.

Whitaker JM, Palefsky JM, Da Costa M, King CM, Johnston JS, Barbosa P. Whitaker JM, et al. Among authors: barbosa p. J Am Podiatr Med Assoc. 2009 Jan-Feb;99(1):8-12. doi: 10.7547/0980008. J Am Podiatr Med Assoc. 2009. PMID: 19141715

9

Plantar verrucae in patients with human immunodeficiency virus. Clinical presentation and treatment response.

Whitaker JM, Gaggero GL, Loveland L, Segura L, Barbosa P. Whitaker JM, et al. Among authors: barbosa p. J Am Podiatr Med Assoc. 2001 Feb;91(2):79-84. doi: 10.7547/87507315-91-2-79. J Am Podiatr Med Assoc. 2001. PMID: 11266482 Clinical Trial.

10

Plantar verrucae and HIV infection.

Barbosa P. Barbosa P. Clin Podiatr Med Surg. 1998 Apr;15(2):317-27. Clin Podiatr Med Surg. 1998. PMID: 9576056 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters